Table 2.
Post-op. findings, recurrences, survival
| Piver II |
Schauta |
p value | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| 37 | 17 | ||||
|
| |||||
| Transfusion | 10 | 26 | 1 | 6 | 0.143 |
| Fever | 0 | 0 | 8 | 47 | 0.048 |
| Therapies associated with surgery | |||||
| Adiuvant Chemotherapy | 17 | 45 | 4 | 24 | 0.210 |
| NACT | 7 | 18 | 0 | 0 | 0.084 |
| Adjuvant Radiotherapy | 22 | 58 | 4 | 24 | 0.028 |
| Neoadjuvant Radiotherapy | 3 | 8 | 0 | 0 | 0.543 |
| Recurrences | 8 | 21 | 3 | 18 | 1.000 |
| central Reccurrences | 5 | 13.2 | 3 | 17.6 | 0.692 |
| extrapelvic metastasis | 3 | 7.9 | 0 | 0 | 0.544 |
| survival at 5 years | 23 | 67.6 | 11 | 78.6 | 0.510 |
| survival at 5 years in FIGO IIB | 6 | 50 | 3 | 50 | 1.000 |
NACT, neo-adjuvant chemotherapy.